Schizophrenia Journal Articles

• Overdose Risk With Co-prescription of Antipsychotics, Opioids This study evaluated the risk of overdose in patients co-prescribed opioids and antipsychotic agents with sedating vs nonsedating properties.
  Schizophrenia Bulletin, May 16, 2022
• Effect of a Novel Nasal Oxytocin Spray on Autism Does this novel intranasal oxytocin spray prove to be an effective therapy for the core social symptoms of autism?
  Brain, May 13, 2022
• Acute Kidney Injury is Linked to Neurocognitive Impairments A new study finds that an episode of acute kidney injury could have negative impacts on neurocognitive functioning.
  Nephrology Dialysis Transplantation, May 04, 2022
• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• Reducing Withdrawal and Relapse After Clozapine Discontinuation Stopping clozapine treatment is challenging due to the risk of psychotic relapse, as well as the development of withdrawal symptoms, but currently there is no formal guidance on how to do so.
  Schizophrenia Bulletin, April 14, 2022
• Early Interventions for Psychosis This review contrasts and compares two models of early intervention for psychosis: the prevention model, and the first-episode recovery model. When should each be used...or is there a better approach?
  Current Psychiatry, April 11, 2022
• Antipsychotic, Sedative Medications in Older ED Patients What factors are associated with the administration of sedatives and antipsychotics in older patients presenting to the emergency department?
  Journal of the American Geriatrics Society, April 05, 2022
• CBT for Prodromal Stage of Psychosis This study assessed the impact of cognitive-behavioral therapy for psychosis on young people at clinically high risk. Can it improve transition rates and psychotic symptoms?
  Schizophrenia Bulletin, March 14, 2022
• Long-term Continuity of Antipsychotic Therapy for Schizophrenia This study measured continuity of antipsychotic treatment in individuals with early phase schizophrenia followed for up to 18 years. What risk factors were associated with interruption of treatment?
  Schizophrenia Bulletin, February 14, 2022
• Neuropsychiatric Manifestations of COVID-19 This review synthesizes the neuropsychiatric manifestations of COVID-19 infection in people with psychiatric disorders. What are the most common neuropsychiatric sequelae affecting these patients?
  Journal of Medical Case Reports, February 01, 2022
• Reducing Stigma Among Youth at Risk for Psychosis This commentary highlights the detrimental impact of stigma and discrimination on youth at clinical high risk for psychosis, stressing the importance of interventions to address this vulnerability.
  Schizophrenia Bulletin, January 14, 2022
• COVID-19 Prevalence and Mortality Among Schizophrenia Patients Are patients with schizophrenia more prone to COVID-19 infection? This study investigated the prevalence of COVID-19 morbidity and mortality in schizophrenic patients compared with controls.
  Schizophrenia Bulletin, December 15, 2021
• Trajectories of Response in Psoriasis Treated With Biologics This study identified subgroups of psoriasis patients that display similar patterns of disease severity and response to biologic therapy over time, with the aim of better informing patient management.
  The British Journal of Dermatology, November 17, 2021
• Antipsychotic Medications: Enhancing Use to Improve Outcomes In this commentary, the authors address remaining gaps in knowledge regarding optimal clinical use of antipsychotic medications.
  Schizophrenia Bulletin, November 15, 2021
• Long-term Effectiveness of Drugs for Schizoaffective Disorder This study compares the long-term real-world effectiveness of sixteen commonly used psychopharmacotherapies in schizoaffective disorder. Which are associated with the best--and worst--outcomes?
  Schizophrenia Bulletin, October 15, 2021
• Refractory Catatonia in Old Age: A Case Report This case of an elderly catatonic patient who was refractory to benzodiazepines and ECT highlights important implications for the management of catatonia in old age.
  Journal of Medical Case Reports, September 29, 2021
• Tapering Antipsychotic Treatment to Minimize Relapse Risk The authors present principles for reducing and discontinuing antipsychotics in a manner that minimizes the risk of withdrawal symptoms and relapse.
  Schizophrenia Bulletin, September 16, 2021
• Neuroimaging Genomics in Autism and Schizophrenia Find out how neuroimaging genomics could help advance our understanding of the genetic and neuropsychiatric variants associated with these conditions.
  Brain, September 14, 2021
• Do Psychological Interventions Work for Adolescent Psychosis? This study aimed to assess the efficacy of various psychological interventions for adolescents with psychosis such as cognitive remediation therapy, psychoeducation, family therapy, and group therapy.
  Schizophrenia Bulletin, August 16, 2021
• Effect of Inadequate Sleep on Frequent Mental Distress Up to one-third of US adults report sleeping less than the recommended amount. Is there a bi-directional relationship between inadequate sleep and mental distress?
  Preventing Chronic Disease, July 23, 2021